208 Chapter 10 REFERENCES 1. Hart- en vaatziekten in de Nederlandse huisartsenpraktijk [updated 06-062024. Available from: https://www. hartenvaatcijfers.nl/artikelen/hart-en- vaatziekten-in-de-nederlandse-huisartsenpraktijk-9cf0a. 2. Mileva N, Nagumo S, Mizukami T, Sonck J, Berry C, Gallinoro E, et al. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis. J Am Heart Assoc. 2022;11(7):e023207. 3. Wang ZJ, Zhang LL, Elmariah S, Han HY, Zhou YJ. Prevalence and Prognosis of Nonobstructive Coronary Artery Disease in Patients Undergoing Coronary Angiography or Coronary Computed Tomography Angiography: A Meta-Analysis. Mayo Clin Proc. 2017;92(3):329-46. 4. Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024. 5. Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas A, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020;41(37):3504-20. 6. Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart. 2018;104(4):284-92. 7. Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J Am Coll Cardiol. 2018;72(23 Pt A):2841-55. 8. Man JJ, Beckman JA, Jaffe IZ. Sex as a Biological Variable in Atherosclerosis. Circ Res. 2020;126(9):1297-319. 9. Xie F, Li X, Xu Y, Cheng D, Xia X, Lv X, et al. Estrogen Mediates an AtheroscleroticProtective Action via Estrogen Receptor Alpha/SREBP-1 Signaling. Front Cardiovasc Med. 2022;9:895916. 10. Poznyak AV, Sukhorukov VN, Guo S, Postnov AY, Orekhov AN. Sex Differences Define the Vulnerability to Atherosclerosis. Clinical Medicine Insights: Cardiology. 2023;17:11795468231189044. 11. Yang Z, Liu Y, Li Z, Feng S, Lin S, Ge Z, et al. Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies. Biomed Pharmacother. 2023;164:115011. 12. Montero D, Diaz-Canestro C, Oberholzer L, Lundby C. The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes. Lancet Diabetes Endocrinol. 2019;7(10):807-16. 13. Nickander J, Themudo R, Sigfridsson A, Xue H, Kellman P, Ugander M. Females have higher myocardial perfusion, blood volume and extracellular volume compared to males - an adenosine stress cardiovascular magnetic resonance study. Sci Rep. 2020;10(1):10380. 14. Vogel R, Indermühle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol. 2005;45(5):754-62. 15. Bulte CSE, Slikkerveer J, Meijer RI, Gort D, Kamp O, Loer SA, et al. ContrastEnhanced Ultrasound for Myocardial Perfusion Imaging. Anesthesia & Analgesia. 2012;114(5):938-45. 16. Kaul S. Myocardial contrast echocardiography: basic principles. Prog Cardiovasc Dis. 2001;44(1):1-11.
RkJQdWJsaXNoZXIy MTk4NDMw